Consensus Estimates For Amazon’s First Quarter Of 2021

Amazon.com Inc (NASDAQ: AMZN) will be reporting its first quarter financial results on April 29th after market close. Analysts have a consensus $3,993.18 12-month price target on the company, via a total of 47 analysts, with 18 analysts having strong buy ratings. 27 analysts meanwhile have buy ratings and, two analysts have hold ratings. The street high comes from Susquehanna Financial with a $5,200 price target, and the lowest target sits at $3,048 from R5 Capital.

36 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 36 analysts is $104.46 billion; this number has been revised upwards from $95.31 billion at the start of the year. The highest revenue estimate is $107.5 billion, while the lowest is $99.5 billion.

The analyst consensus for net income for the first quarter is $4.96 billion, this is up from the start of the year which was $4.79 billion. The highest net income estimate is $6.14 billion, while the lowest is $3.3 billion.

Onto EBITDA estimates, there are currently 26 analysts who have first-quarter EBITDA estimates. The mean is currently $15.84 billion, with this number having been revised up from $14.84 billion at the start of the year. The street high estimate currently sits at $18 billion in EBITDA and the lowest is $14.13 billion.

Analysts estimate that quarterly earnings per share will come in at $9.54, with this number being slightly revised up from $9.04 at the start of the year. Street high is $12.00 and the lowest estimate is $6.41 per share for the quarter.


Video Articles

Agnico Q1 Earnings Results Overshadowed By A Sinking Gold Price

Why More People Are Starting to Feel Broke | Darrell Thomas – VRIC Media

Newmont Q1 Earnings: A Billion In Free Cash Flow… A Month!

Recommended

Altamira Gold Extends Maria Bonita Porphyry System Westward With 70.6 Metres At 0.51 g/t Hit

Antimony Resources Reports 13.9% Antimony in Latest Drill Core at Bald Hill

Related News

Antibe Therapeutics: Canaccord Upgrades Price Target To $16.50

Earlier this week, Antibe Therapeutics (TSXV: ATE) announced a strategic licensing deal with Nuance Pharm...

Thursday, February 11, 2021, 04:07:00 PM

Jeff Bezos’ Wealth Surges to New Record After Pentagon Cancels JEDI Contract With Microsoft

Jeff Bezos has now anchored his position as the world’s wealthiest person in modern history,...

Saturday, July 10, 2021, 03:11:00 PM

Tilray Sees Haywood Slash Price Target To $12.50

On October 7, Tilray Inc (TSX: TLRY) reported their first quarter financial results for the...

Sunday, October 10, 2021, 04:49:00 PM

Galaxy Digital: BMO Initiates With $43 Price Target

Galaxy Digital Holdings (TSX: GLXY), a hodgepodge of different crypto businesses under one company, just...

Wednesday, November 3, 2021, 04:08:00 PM

Microsoft: Earnings Estimates For Q1 2022

Microsoft (NASDAQ: MSFT) will be reporting its first quarter financial results on the 26th after...

Monday, October 25, 2021, 04:01:00 PM